Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.
Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, Brito-Sanfiel M, Umpierrez G. Gomez-Peralta F, et al. Among authors: morales c. Diabetes Ther. 2017 Oct;8(5):953-962. doi: 10.1007/s13300-017-0277-0. Epub 2017 Jul 18. Diabetes Ther. 2017. PMID: 28721687 Free PMC article. Review.
Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.
Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, Brito-Sanfiel M, Umpierrez G. Gomez-Peralta F, et al. Among authors: morales c. Diabetes Ther. 2017 Oct;8(5):963-965. doi: 10.1007/s13300-017-0290-3. Diabetes Ther. 2017. PMID: 28836177 Free PMC article. No abstract available.
Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
Rosenstock J, Sorli CH, Trautmann ME, Morales C, Wendisch U, Dailey G, Hompesch M, Choi IY, Kang J, Stewart J, Yoon KH. Rosenstock J, et al. Among authors: morales c. Diabetes Care. 2019 Sep;42(9):1733-1741. doi: 10.2337/dc18-2648. Epub 2019 Jul 18. Diabetes Care. 2019. PMID: 31320446 Free article. Clinical Trial.
Implementation of subcutaneous insulin protocol for non-critically ill hospitalized patients in andalusian tertiary care hospitals.
Martínez-Brocca MA, Morales C, Rodríguez-Ortega P, González-Aguilera B, Montes C, Colomo N, Piédrola G, Méndez-Muros M, Serrano I, Ruiz de Adana MS, Moreno A, Fernández I, Aguilar M, Acosta D, Palomares R. Martínez-Brocca MA, et al. Among authors: morales c. Endocrinol Nutr. 2015 Feb;62(2):64-71. doi: 10.1016/j.endonu.2014.09.006. Epub 2014 Nov 20. Endocrinol Nutr. 2015. PMID: 25467634 English, Spanish.
Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation.
Chico A, Aguilera E, Ampudia-Blasco FJ, Bellido V, Cardona-Hernández R, Escalada FJ, Fernández D, Gómez-Peralta F, González Pérez de Villar N, Gorgojo JJ, Mezquita-Raya P, Morales C, de Pablos Velasco P, Palomares R, Parra J, Rivero MT, González-Blanco C. Chico A, et al. Among authors: morales c. J Diabetes Sci Technol. 2020 Jan;14(1):155-164. doi: 10.1177/1932296819841911. Epub 2019 May 12. J Diabetes Sci Technol. 2020. PMID: 31081362 Free PMC article.
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Among authors: morales c. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
1,199 results